Global Autism Spectrum Disorder (ASD) Treatment Market Growth (Status and Outlook) 2022-2028
As the global economy mends, the 2021 growth of Autism Spectrum Disorder (ASD) Treatment will have significant change from previous year. According to our (LP Information) latest study, the global Autism Spectrum Disorder (ASD) Treatment market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Autism Spectrum Disorder (ASD) Treatment market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States Autism Spectrum Disorder (ASD) Treatment market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Autism Spectrum Disorder (ASD) Treatment market, reaching US$ million by the year 2028. As for the Europe Autism Spectrum Disorder (ASD) Treatment landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Autism Spectrum Disorder (ASD) Treatment players cover Pfizer, SynapDx, Behavior Analysis, and Autism Therapeutics, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Autism Spectrum Disorder (ASD) Treatment market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Applied Behavior Analysis (ABA)
Discrete Trial Training (DTT)
Pivotal Response Training (PRT)
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Autistic Disorder
Asperger Syndrome
Pervasive Developmental Disorder
Childhood Disintegrative Disorder
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Pfizer
SynapDx
Behavior Analysis
Autism Therapeutics
Curemark
Roche Pharmaceuticals
Fraser
Retrophin
AutismSTEP
Please note: The report will take approximately 2 business days to prepare and deliver.
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Years Considered
- 1.3 Research Objectives
- 1.4 Market Research Methodology
- 1.5 Research Process and Data Source
- 1.6 Economic Indicators
- 1.7 Currency Considered
- 2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Autism Spectrum Disorder (ASD) Treatment Market Size 2017-2028
- 2.1.2 Autism Spectrum Disorder (ASD) Treatment Market Size CAGR by Region 2017 VS 2022 VS 2028
- 2.2 Autism Spectrum Disorder (ASD) Treatment Segment by Type
- 2.2.1 Applied Behavior Analysis (ABA)
- 2.2.2 Discrete Trial Training (DTT)
- 2.2.3 Pivotal Response Training (PRT)
- 2.2.4 Others
- 2.3 Autism Spectrum Disorder (ASD) Treatment Market Size by Type
- 2.3.1 Autism Spectrum Disorder (ASD) Treatment Market Size CAGR by Type (2017 VS 2022 VS 2028)
- 2.3.2 Global Autism Spectrum Disorder (ASD) Treatment Market Size Market Share by Type (2017-2022)
- 2.4 Autism Spectrum Disorder (ASD) Treatment Segment by Application
- 2.4.1 Autistic Disorder
- 2.4.2 Asperger Syndrome
- 2.4.3 Pervasive Developmental Disorder
- 2.4.4 Childhood Disintegrative Disorder
- 2.5 Autism Spectrum Disorder (ASD) Treatment Market Size by Application
- 2.5.1 Autism Spectrum Disorder (ASD) Treatment Market Size CAGR by Application (2017 VS 2022 VS 2028)
- 2.5.2 Global Autism Spectrum Disorder (ASD) Treatment Market Size Market Share by Application (2017-2022)
- 3 Autism Spectrum Disorder (ASD) Treatment Market Size by Player
- 3.1 Autism Spectrum Disorder (ASD) Treatment Market Size Market Share by Players
- 3.1.1 Global Autism Spectrum Disorder (ASD) Treatment Revenue by Players (2020-2022)
- 3.1.2 Global Autism Spectrum Disorder (ASD) Treatment Revenue Market Share by Players (2020-2022)
- 3.2 Global Autism Spectrum Disorder (ASD) Treatment Key Players Head office and Products Offered
- 3.3 Market Concentration Rate Analysis
- 3.3.1 Competition Landscape Analysis
- 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
- 3.4 New Products and Potential Entrants
- 3.5 Mergers & Acquisitions, Expansion
- 4 Autism Spectrum Disorder (ASD) Treatment by Regions
- 4.1 Autism Spectrum Disorder (ASD) Treatment Market Size by Regions (2017-2022)
- 4.2 Americas Autism Spectrum Disorder (ASD) Treatment Market Size Growth (2017-2022)
- 4.3 APAC Autism Spectrum Disorder (ASD) Treatment Market Size Growth (2017-2022)
- 4.4 Europe Autism Spectrum Disorder (ASD) Treatment Market Size Growth (2017-2022)
- 4.5 Middle East & Africa Autism Spectrum Disorder (ASD) Treatment Market Size Growth (2017-2022)
- 5 Americas
- 5.1 Americas Autism Spectrum Disorder (ASD) Treatment Market Size by Country (2017-2022)
- 5.2 Americas Autism Spectrum Disorder (ASD) Treatment Market Size by Type (2017-2022)
- 5.3 Americas Autism Spectrum Disorder (ASD) Treatment Market Size by Application (2017-2022)
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Brazil
- 6 APAC
- 6.1 APAC Autism Spectrum Disorder (ASD) Treatment Market Size by Region (2017-2022)
- 6.2 APAC Autism Spectrum Disorder (ASD) Treatment Market Size by Type (2017-2022)
- 6.3 APAC Autism Spectrum Disorder (ASD) Treatment Market Size by Application (2017-2022)
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 7 Europe
- 7.1 Europe Autism Spectrum Disorder (ASD) Treatment by Country (2017-2022)
- 7.2 Europe Autism Spectrum Disorder (ASD) Treatment Market Size by Type (2017-2022)
- 7.3 Europe Autism Spectrum Disorder (ASD) Treatment Market Size by Application (2017-2022)
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 8 Middle East & Africa
- 8.1 Middle East & Africa Autism Spectrum Disorder (ASD) Treatment by Region (2017-2022)
- 8.2 Middle East & Africa Autism Spectrum Disorder (ASD) Treatment Market Size by Type (2017-2022)
- 8.3 Middle East & Africa Autism Spectrum Disorder (ASD) Treatment Market Size by Application (2017-2022)
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
- 9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers & Growth Opportunities
- 9.2 Market Challenges & Risks
- 9.3 Industry Trends
- 10 Global Autism Spectrum Disorder (ASD) Treatment Market Forecast
- 10.1 Global Autism Spectrum Disorder (ASD) Treatment Forecast by Regions (2023-2028)
- 10.1.1 Global Autism Spectrum Disorder (ASD) Treatment Forecast by Regions (2023-2028)
- 10.1.2 Americas Autism Spectrum Disorder (ASD) Treatment Forecast
- 10.1.3 APAC Autism Spectrum Disorder (ASD) Treatment Forecast
- 10.1.4 Europe Autism Spectrum Disorder (ASD) Treatment Forecast
- 10.1.5 Middle East & Africa Autism Spectrum Disorder (ASD) Treatment Forecast
- 10.2 Americas Autism Spectrum Disorder (ASD) Treatment Forecast by Country (2023-2028)
- 10.2.1 United States Autism Spectrum Disorder (ASD) Treatment Market Forecast
- 10.2.2 Canada Autism Spectrum Disorder (ASD) Treatment Market Forecast
- 10.2.3 Mexico Autism Spectrum Disorder (ASD) Treatment Market Forecast
- 10.2.4 Brazil Autism Spectrum Disorder (ASD) Treatment Market Forecast
- 10.3 APAC Autism Spectrum Disorder (ASD) Treatment Forecast by Region (2023-2028)
- 10.3.1 China Autism Spectrum Disorder (ASD) Treatment Market Forecast
- 10.3.2 Japan Autism Spectrum Disorder (ASD) Treatment Market Forecast
- 10.3.3 Korea Autism Spectrum Disorder (ASD) Treatment Market Forecast
- 10.3.4 Southeast Asia Autism Spectrum Disorder (ASD) Treatment Market Forecast
- 10.3.5 India Autism Spectrum Disorder (ASD) Treatment Market Forecast
- 10.3.6 Australia Autism Spectrum Disorder (ASD) Treatment Market Forecast
- 10.4 Europe Autism Spectrum Disorder (ASD) Treatment Forecast by Country (2023-2028)
- 10.4.1 Germany Autism Spectrum Disorder (ASD) Treatment Market Forecast
- 10.4.2 France Autism Spectrum Disorder (ASD) Treatment Market Forecast
- 10.4.3 UK Autism Spectrum Disorder (ASD) Treatment Market Forecast
- 10.4.4 Italy Autism Spectrum Disorder (ASD) Treatment Market Forecast
- 10.4.5 Russia Autism Spectrum Disorder (ASD) Treatment Market Forecast
- 10.5 Middle East & Africa Autism Spectrum Disorder (ASD) Treatment Forecast by Region (2023-2028)
- 10.5.1 Egypt Autism Spectrum Disorder (ASD) Treatment Market Forecast
- 10.5.2 South Africa Autism Spectrum Disorder (ASD) Treatment Market Forecast
- 10.5.3 Israel Autism Spectrum Disorder (ASD) Treatment Market Forecast
- 10.5.4 Turkey Autism Spectrum Disorder (ASD) Treatment Market Forecast
- 10.5.5 GCC Countries Autism Spectrum Disorder (ASD) Treatment Market Forecast
- 10.6 Global Autism Spectrum Disorder (ASD) Treatment Forecast by Type (2023-2028)
- 10.7 Global Autism Spectrum Disorder (ASD) Treatment Forecast by Application (2023-2028)
- 11 Key Players Analysis
- 11.1 Pfizer
- 11.1.1 Pfizer Company Information
- 11.1.2 Pfizer Autism Spectrum Disorder (ASD) Treatment Product Offered
- 11.1.3 Pfizer Autism Spectrum Disorder (ASD) Treatment Revenue, Gross Margin and Market Share (2020-2022)
- 11.1.4 Pfizer Main Business Overview
- 11.1.5 Pfizer Latest Developments
- 11.2 SynapDx
- 11.2.1 SynapDx Company Information
- 11.2.2 SynapDx Autism Spectrum Disorder (ASD) Treatment Product Offered
- 11.2.3 SynapDx Autism Spectrum Disorder (ASD) Treatment Revenue, Gross Margin and Market Share (2020-2022)
- 11.2.4 SynapDx Main Business Overview
- 11.2.5 SynapDx Latest Developments
- 11.3 Behavior Analysis
- 11.3.1 Behavior Analysis Company Information
- 11.3.2 Behavior Analysis Autism Spectrum Disorder (ASD) Treatment Product Offered
- 11.3.3 Behavior Analysis Autism Spectrum Disorder (ASD) Treatment Revenue, Gross Margin and Market Share (2020-2022)
- 11.3.4 Behavior Analysis Main Business Overview
- 11.3.5 Behavior Analysis Latest Developments
- 11.4 Autism Therapeutics
- 11.4.1 Autism Therapeutics Company Information
- 11.4.2 Autism Therapeutics Autism Spectrum Disorder (ASD) Treatment Product Offered
- 11.4.3 Autism Therapeutics Autism Spectrum Disorder (ASD) Treatment Revenue, Gross Margin and Market Share (2020-2022)
- 11.4.4 Autism Therapeutics Main Business Overview
- 11.4.5 Autism Therapeutics Latest Developments
- 11.5 Curemark
- 11.5.1 Curemark Company Information
- 11.5.2 Curemark Autism Spectrum Disorder (ASD) Treatment Product Offered
- 11.5.3 Curemark Autism Spectrum Disorder (ASD) Treatment Revenue, Gross Margin and Market Share (2020-2022)
- 11.5.4 Curemark Main Business Overview
- 11.5.5 Curemark Latest Developments
- 11.6 Roche Pharmaceuticals
- 11.6.1 Roche Pharmaceuticals Company Information
- 11.6.2 Roche Pharmaceuticals Autism Spectrum Disorder (ASD) Treatment Product Offered
- 11.6.3 Roche Pharmaceuticals Autism Spectrum Disorder (ASD) Treatment Revenue, Gross Margin and Market Share (2020-2022)
- 11.6.4 Roche Pharmaceuticals Main Business Overview
- 11.6.5 Roche Pharmaceuticals Latest Developments
- 11.7 Fraser
- 11.7.1 Fraser Company Information
- 11.7.2 Fraser Autism Spectrum Disorder (ASD) Treatment Product Offered
- 11.7.3 Fraser Autism Spectrum Disorder (ASD) Treatment Revenue, Gross Margin and Market Share (2020-2022)
- 11.7.4 Fraser Main Business Overview
- 11.7.5 Fraser Latest Developments
- 11.8 Retrophin
- 11.8.1 Retrophin Company Information
- 11.8.2 Retrophin Autism Spectrum Disorder (ASD) Treatment Product Offered
- 11.8.3 Retrophin Autism Spectrum Disorder (ASD) Treatment Revenue, Gross Margin and Market Share (2020-2022)
- 11.8.4 Retrophin Main Business Overview
- 11.8.5 Retrophin Latest Developments
- 11.9 AutismSTEP
- 11.9.1 AutismSTEP Company Information
- 11.9.2 AutismSTEP Autism Spectrum Disorder (ASD) Treatment Product Offered
- 11.9.3 AutismSTEP Autism Spectrum Disorder (ASD) Treatment Revenue, Gross Margin and Market Share (2020-2022)
- 11.9.4 AutismSTEP Main Business Overview
- 11.9.5 AutismSTEP Latest Developments
- 12 Research Findings and Conclusion
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook